Tuesday, May 08, 2018 9:19:05 AM
ADR is 3:1 - NICE!
60 percent upside
Added 36.83 US stock
Added 29.38 US cash
Not a bad deal!
Never Never buy/sell any security based on my post(s). I DO NOT receive any compensation in any form (cash or shares) from any company or 3rd party mentioned in my post(s). All my posts are my OPINION only.
ALWAYS CHECK WITH A FINANCIAL ADVISER
Recent TAK News
- Takeda Receives Approval for FRUZAQLA (fruquintinib) in Japan for the Treatment of Unresectable Advanced or Recurrent Colorectal Cancer • Business Wire • 09/24/2024 07:00:00 AM
- HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda • GlobeNewswire Inc. • 09/24/2024 07:00:00 AM
- Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024 • Business Wire • 09/19/2024 12:00:00 PM
- Takeda s'engage à verser plus de 32 millions de dollars dans le cadre de cinq nouveaux partenariats internationaux en faveur de la responsabilité sociale des entreprises (RSE), afin de renforcer sa contribution à la santé au sein de 93 pays • Business Wire • 09/19/2024 04:38:00 AM
- Takeda stellt über 32 Mio. US-Dollar für fünf neue globale Partnerschaften im Bereich der sozialen Verantwortung von Unternehmen bereit, um die Gesundheit in 93 Ländern weiter zu verbessern • Business Wire • 09/19/2024 04:36:00 AM
- 5つの新しいグローバルCSRパートナーシップに3,200万ドル以上を拠出し、93カ国における健康増進を支援 • Business Wire • 09/18/2024 02:00:00 PM
- Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries • Business Wire • 09/18/2024 02:00:00 PM
- Vatroslav Mateljic est nommé directeur général de Takeda Canada • PR Newswire (Canada) • 09/16/2024 12:40:00 PM
- Vatroslav Mateljic Appointed General Manager of Takeda Canada • PR Newswire (Canada) • 09/16/2024 12:39:00 PM
- Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (cTTP) • Business Wire • 08/07/2024 10:45:00 AM
- Takeda annonce ses résultats financiers pour le premier trimestre de son exercice 2024 – Excellente performance au niveau des produits de croissance et de lancement ; des progrès dans le pipeline prometteur à un stade avancé • Business Wire • 07/31/2024 10:17:00 PM
- Takeda gibt Ergebnisse für das erste Quartal des Geschäftsjahres 2024 bekannt - Starke Leistung von Wachstums- und Einführungsprodukten; Fortschritte in der vielversprechenden Pipeline im Spätstadium • Business Wire • 07/31/2024 10:07:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 07/31/2024 11:46:49 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/31/2024 10:02:04 AM
- AMD Shares Surge 9% on Earnings Beat; Match Group Rises 10%, Pinterest & Lemonade Drop 13%, and More Earnings Updates • IH Market News • 07/31/2024 09:59:10 AM
- Takeda Announces First Quarter FY2024 Results - Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline • Business Wire • 07/31/2024 06:06:00 AM
- 2024年度第1四半期業績を公表 - 成長製品・新製品は力強い勢いを示し、後期開発段階の有望なパイプラインが進展 • Business Wire • 07/31/2024 06:06:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/10/2024 11:19:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/10/2024 11:18:17 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/10/2024 11:17:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/10/2024 11:17:08 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/10/2024 11:16:39 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/10/2024 11:16:15 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/10/2024 11:15:38 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/10/2024 11:15:04 AM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM